Investment Institute
Macroeconomic Research

Framing the ECB’s rate cutting cycle

  • 26 February 2024 (10 min read)

Key points:

  • Market pricing was a poor predictor of actual ECB decisions in the last interest rate hiking cycle. Detailed analysis suggests market expectations more than two to three weeks before an ECB meeting should be viewed with great caution
  • The Orphanides-Wieland rule suggests some upside to our – and the market’s – baseline of a 25-basis-point (bp) ECB rate cut in June. Further out, the Taylor rule highlights that rates could fall by more than the 125bp we predict by end-2025
  • We believe it is worth stepping back from these well-known, yet simple, policy rate rules. The ECB is likely to maintain a more holistic approach, including risk management
  • A cautious approach to using these rules is paramount, reinforced by two key uncertainties – the Eurozone faces multiple large (negative) supply structural changes, which may imply higher price pressures than in the past. Second, fiscal policy in the context of the new Eurozone framework may also be more inflationary than in the past

     
Brick by Brick: Unravelling China's property Puzzle
Macroeconomics Macroeconomic Research

Brick by Brick: Unravelling China's property Puzzle

  • by Yingrui Wang
  • 02 May 2024 (10 min read)
Investment Institute
Framing the ECB’s rate cutting cycle
Macroeconomics Macroeconomic Research

Framing the ECB’s rate cutting cycle

Investment Institute
2024’s elections around the world: The who’s who and the so what…
Macroeconomics Macroeconomic Research

2024’s elections around the world: The who’s who and the so what…

  • by Irina Topa-Serry, Luis Lopez-Vivas, and others
  • 23 January 2024 (7 min read)
Investment Institute

    Disclaimer

    This website is published by AXA Investment Managers Asia (Singapore) Ltd. (Registration No. 199001714W) for general circulation and informational purposes only. It does not constitute investment research or financial analysis relating to transactions in financial instruments, nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities. It has been prepared without taking into account the specific personal circumstances, investment objectives, financial situation or particular needs of any particular person and may be subject to change without notice. Please consult your financial or other professional advisers before making any investment decision.

    Due to its simplification, this publication is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this publication is provided based on our state of knowledge at the time of creation of this publication. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    All investment involves risk, including the loss of capital. The value of investments and the income from them can fluctuate and investors may not get back the amount originally invested. Past performance is not necessarily indicative of future performance.

    Some of the Services and/or products may not be available for offer to retail investors.

    This publication has not been reviewed by the Monetary Authority of Singapore.